We believe in the power of biomarker diagnostics to transform cardiovascular healthcare.
Marker C — a patented diagnostic blood test
Chest pain patients at the ED that fall into the troponin grey-zone and so are unable to be rapidly triaged. Approx 1 in 3 chest pain patients.
Further assess 1 of 2 patients admitted to the hospital with elevated troponin who are found to not have an MI.
Patients with suspected risk of coronary artery disease referred by their primary carer for a cardiac stress test. In the US this is $5.6m p.a.
Contact us to learn more about Upstream's solution.